152 related articles for article (PubMed ID: 1471069)
1. Neutralization of the antithrombotic effects of heparin and Fraxiparin by protamine sulfate.
Racanelli A; Fareed J
Thromb Res; 1992 Nov; 68(3):211-22. PubMed ID: 1471069
[TBL] [Abstract][Full Text] [Related]
2. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate.
Maddineni J; Hoppensteadt DA; Cornelli U; Manoni M; Fareed J
Clin Appl Thromb Hemost; 2007 Jan; 13(1):52-64. PubMed ID: 17164496
[TBL] [Abstract][Full Text] [Related]
3. In vivo neutralization of unfractionated heparin and low-molecular-weight heparin by a novel salicylamide derivative.
Kuziej J; Litinas E; Hoppensteadt DA; Liu D; Walenga JM; Fareed J; Jeske W
Clin Appl Thromb Hemost; 2010 Aug; 16(4):377-86. PubMed ID: 20460347
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo activity of heparin is not predictive of blood loss after neutralization by protamine.
Racanelli A; Fareed J
Thromb Res; 1992 Jul; 67(2):263-73. PubMed ID: 1332215
[TBL] [Abstract][Full Text] [Related]
5. [Antithrombotic properties of heparin independent of its anticoagulant activity].
Krupiński K; Bielawiec M; Breddin HK
Acta Haematol Pol; 1994; 25(3):243-51. PubMed ID: 7992597
[TBL] [Abstract][Full Text] [Related]
6. Neutralization of a low molecular weight heparin (LHN-1) and conventional heparin by protamine sulfate in rats.
Diness V; Ostergaard PB
Thromb Haemost; 1986 Dec; 56(3):318-22. PubMed ID: 3563964
[TBL] [Abstract][Full Text] [Related]
7. Partial reversal of low molecular weight heparin (PK 10169) anti-Xa activity by protamine sulfate: in vitro and in vivo study during cardiac surgery with extracorporeal circulation.
Massonnet-Castel S; Pelissier E; Bara L; Terrier E; Abry B; Guibourt P; Swanson J; Jaulmes B; Carpentier A; Samama M
Haemostasis; 1986; 16(2):139-46. PubMed ID: 3710291
[TBL] [Abstract][Full Text] [Related]
8. Neutralase reverses the anti-coagulant but not the anti-thrombotic activity of heparin in a rabbit model of venous thrombosis.
Silver PJ; Broughton R; Bouthillier J; Quinn TA; Wallace AM; Weishaar RE
Thromb Res; 1998 Aug; 91(3):143-50. PubMed ID: 9733158
[TBL] [Abstract][Full Text] [Related]
9. Andexanet Alfa Neutralizes the Anticoagulant Effects of Unfractionated Heparin of Bovine, Ovine and Porcine Origin Almost as Protamine Sulfate.
Siddiqui F; Hoppensteadt D; Jeske W; Ramacciotti E; Tafur A; Fareed J
Clin Appl Thromb Hemost; 2024; 30():10760296241247558. PubMed ID: 38656136
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of heparin and LMW heparin on hemostasis.
Hirsh J; Buchanan MR
Thromb Res Suppl; 1991; 14():11-7. PubMed ID: 1658966
[TBL] [Abstract][Full Text] [Related]
11. Comparative study on the in vitro and in vivo activities of heparinoids derivative investigated on the animal model.
Giedrojć J; Klimiuk M; Radziwon P; Kłoczko J; Bielawiec M; Breddin HK
J Cardiovasc Pharmacol; 1999 Sep; 34(3):340-5. PubMed ID: 10470990
[TBL] [Abstract][Full Text] [Related]
12. Neutralization of enoxaparine-induced bleeding by protamine sulfate.
Van Ryn-McKenna J; Cai L; Ofosu FA; Hirsh J; Buchanan MR
Thromb Haemost; 1990 Apr; 63(2):271-4. PubMed ID: 2163553
[TBL] [Abstract][Full Text] [Related]
13. Protamine neutralization of the release of tissue factor pathway inhibitor activity by heparins.
Harenberg J; Siegele M; Dempfle CE; Stehle G; Heene DL
Thromb Haemost; 1993 Dec; 70(6):942-5. PubMed ID: 8165616
[TBL] [Abstract][Full Text] [Related]
14. Chemical and pharmacological aspects of neutralization of heparins from different animal sources by protamine.
Glauser BF; Santos GRC; Silva JD; Tovar AMF; Pereira MS; Vilanova E; Mourão PAS
J Thromb Haemost; 2018 Sep; 16(9):1789-1799. PubMed ID: 29968421
[TBL] [Abstract][Full Text] [Related]
15. [Neutralization of low molecular weight heparin Kabi 2165 by protamine chloride].
Harenberg J; Giese C; Knödler A; Zimmermann R; Schettler G
Klin Wochenschr; 1986 Nov; 64(22):1171-5. PubMed ID: 3807263
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of SR 90107A/Org 31540-induced bleeding by protamine sulfate in rats and mice.
Bernat A; Hoffmann P; Herbert JM
Thromb Haemost; 1996 Nov; 76(5):715-9. PubMed ID: 8950779
[TBL] [Abstract][Full Text] [Related]
17. Neutralization of the anticoagulant activity of low molecular weight heparin LU 47311 (Clivarin) in man by protamine chloride.
Andrassy K; Eschenfelder V; Weber E
Thromb Res; 1994 Jan; 73(2):85-93. PubMed ID: 8171416
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic and thrombolytic activity of heparins in a rat model of laser-induced thrombosis.
Krupiński K; Giedrojć J; Breddin HK; Bielawiec M
Pol J Pharmacol; 1996; 48(3):345-50. PubMed ID: 9112675
[TBL] [Abstract][Full Text] [Related]
19. In vivo neutralization of low-molecular weight heparin fraction CY 216 by protamine.
Doutremépuich C; Bonini F; Toulemonde F; Bertrand H; Bayrou B; Quilichini R
Semin Thromb Hemost; 1985 Jul; 11(3):318-22. PubMed ID: 4048954
[TBL] [Abstract][Full Text] [Related]
20. Neutralization of DHG, a new depolymerized holothurian glycosaminoglycan, by protamine sulfate and platelet factor 4.
Sasaki E; Minamiguchi K; Kitazato KT; Nagase H; Kitazato K
Haemostasis; 1997; 27(4):174-83. PubMed ID: 9483172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
